|
A procedure that involves putting heated chemotherapy drugs in direct contact with the site of a mesothelioma tumor after surgery may improve the outlook for people with malignant pleural mesothelioma. A similar procedure is already being used to treat people with peritoneal mesothelioma, a type of cancer that occurs in the lining of the abdomen. The heated chemotherapy rinse can be used after surgery to kill residual mesothelioma cells in the abdomen and lessen the chance of cancer recurrence. Peritoneal mesothelioma is less common than pleural mesothelioma, which occurs on the lining surrounding the lungs. Pleural mesothelioma is usually treated with standard chemotherapy and sometimes surgery and/or radiotherapy. But two recent studies suggest that rinsing the surgical site with heated chemotherapy drugs after cytoreductive surgery may produce better survival odds in pleural mesothelioma just as it has in peritoneal mesothelioma. The most recent study included 160 Japanese patients with various types of pleural malignancies, including 25 with mesothelioma. Patients in the study were all treated between 1987 and 2010 with a platinum-based drug (cisplatin or carboplatin) that was introduced directly into the thoracic cavity after cytoreductive surgery. An 8.00 MHz radiofrequency heating device was used to heat the drugs as soon as they were administered. The five-year overall survival among mesothelioma patients in that study was 15.9%. Nearly a quarter of them had experienced no local recurrence of their cancer. A similar German study published earlier this year found that 4 out of 8 pleural mesothelioma patients were still living at the 22-month follow-up, two of them with “no evidence of mesothelioma” after they had surgery and a heated chemotherapy perfusion. The patients in that study also received systemic chemotherapy and, in some cases, radiotherapy. The research results were published in the European Journal of Cardiothoracic Surgery. Mesothelioma is one of the rarest and most deadly types of cancer. Triggered almost exclusively by exposure to asbestos, it affects an estimated 2,500 Americans each year. Most will not live beyond a year after diagnosis. Disclaimer: The information in this article is for educational and informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this article. This article was written by a third party and its content reflects the views of the third party and does not necessarily reflect the views or opinions or of Surviving Mesothelioma or Cancer Monthly. If anyone is in the unfortunate position to be suffering from Mesothelioma compensation they are likely to be offered with choice of treatments, which were dependent upon the several factors. To know more about Mesothelioma lung cancer just do visit us.
Related Articles -
Mesothelioma lawyer, Mesothelioma lawyers, Pleural mesothelioma, Mesothelioma, Mesothelioma symptoms, mesothelioma survival, Mesothelioma cancer, Mesotheliom,
| 
